Immunic market cap

Author: txhi

August undefined, 2024

Witryna5 kwi 2024 · Immunic Reports Positive Data from Maintenance Phase of Phase 2 CALDOSE-1 Trial of Vidofludimus Calcium in Moderate-to-Severe April 5, 2024, 10:30 AM UTC Share this article Witryna6 kwi 2024 · Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need – Conference Call and Webcast to be Held Today, February 9, 2024, at 11:00 am ET – NEW YORK , Feb. 9, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage …

Witryna6 kwi 2024 · In depth view into Immunic Market Cap including historical data from 2014, charts and stats. Immunic Inc (IMUX) ... Market Capitalization measures the total … WitrynaFind the latest Immunic, Inc. (IMUX) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Market Cap: 61.277M: Beta (5Y Monthly) 1.70: PE ... open herpes sore treatment

Immunic, Inc. Announces Closing of $103.5 Million Public Offering ...

Witryna2 dni temu · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC). Vitt describes it as "wonderful data" that came as a "positive … Witryna31 mar 2024 · Immunic has a market cap or net worth of $66.16 million as of April 1, 2024. Its market cap has decreased by -79.28% in one year. Market Cap 66.16M. … WitrynaHistorical daily share price chart and data for Immunic since 2024 adjusted for splits. The latest closing stock price for Immunic as of February 27, 2024 is 1.89.. The all-time high Immunic stock closing price was 1332.40 on June 16, 2014.; The Immunic 52-week high stock price is 12.64, which is 568.8% above the current share price.; The … open high chartink

Immunic (Nasdaq:IMUX) - Stock Price, News & Analysis - Simply …

Immunic, Inc. Announces $60.0 Million Oversubscribed Private …

Witryna15 kwi 2024 · Aegis Capital bewertet die Aktie positiv mit einem Kauf-Rating. 22 März 2024 ... Veganer Markt. Rating nach Charttechnik. Überverkaufte Aktien. Überkaufte Aktien. Nahe am Widerstand. ... News auf Englisch zu IMMUNIC, INC. 13.03. Immunic, Inc. : Regulation FD Disclosure (form 8-K) AQ. 23.02. Immunic : Q4 2024 News … WitrynaMarket Cap-1M Daily Avg. Vol-3Y P/B Range - 52W Range - 3Y P/S Range - 3Y DivYield Range - Company Info. more arrow_right. Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerat... o pen hero grownWitryna14 kwi 2024 · Immunic Inc (IMUX) is down -5.26%% today. IMUX has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on IMUX!See Full IMUX ReportIMUX stock closed at $1.52 ... openhighhat.deviantart.com

"WitrynaChardan Capital Markets: Buy: $40: Show Previous Ratings Apr-13-23 08:00AM: Immunic gets a "positive surprise" from lead asset trial. News Direct. Apr-06-23 … " - Immunic market cap

Immunic market cap

Immunic reports another trial flop, and execs blame ‘confounded ...

Witryna15 kwi 2024 · Stock split history for Immunic (IMUX) Immunic stock (symbol: IMUX) underwent a total of 1 stock split. The stock split occured on April 15th, 2024. ... The … Witryna12 kwi 2024 · SVB Securities Reaffirms Their Hold Rating on Immunic (IMUX) markets.businessinsider.com - November 21 at 10:04 AM: Immunic, Inc. (IMUX) Q3 2024 Earnings Call Transcript seekingalpha.com - November 6 at 5:38 AM: Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update …

Did you know?

Witryna10 kwi 2024 · A high-level overview of Immunic, Inc. (IMUX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Witryna3 lis 2024 · Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update. News provided by. Immunic, Inc. Nov 03, 2024, 06:30 ET. – $72.8 Million in Cash and Cash Equivalents as ...

WitrynaCurrent and historical revenue charts for Immunic. As of March 2024 Immunic's TTM revenue is of N/A. companies: 7,320 total market cap: $84.507 T. Global ranking; … Witryna7 kwi 2024 · MoneyLion Inc.’s market cap currently stands at around $133.26 million, with investors looking forward to this quarter’s earnings report slated for May 10, 2024 – May 15, 2024. Analysts project the company’s earnings per share (EPS) to be -$0.06, which has seen fiscal year 2024 EPS growth forecast to increase to -$0.21 and about …

Witryna10 paź 2024 · NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX) ("Immunic" or the "Company"), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology ... WitrynaCompany information for Immunic Inc USD0.0001 share priceincluding general stock details, key personnel and important dates for your diary. ... Market cap: $78.15 million Shares in issue: 44.40 ...

WitrynaImmunic market cap history and chart from 2013 to 2024. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Immunic market cap as of September 23, 2024 is $0.1B .

WitrynaImmunic (IMUX) - Net assets Net assets on the balance sheet as of December 2024 : $0.11 B. According to Immunic's latest financial reports the company has $0.11 B in … open hersheys barWitryna21 paź 2024 · Four months after taking an axe to the pipeline resulting from a Phase II miss, Immunic is back with another miss. ... RBC Capital Markets’ Healthcare Technology Analyst, Sean Dodge, spotlights ... open highWitrynaAs of March 2024 Immunic has a market cap of $70.15 Million . This makes Immunic the world's 6697th most valuable company by market cap according to our data. The … open hevc file windows 11WitrynaAktien, Aktienkurse, Devisenkurse und Währungsrechner, Rohstoffkurse. Informationen rund um die Börse zu Aktie, Fonds und ETFs. Börsenkurse für Optionsscheine und Zertifikate. Aktienanalysen - finanzen.net open hiatal hernia repair surgeryWitryna20 paź 2024 · The EIB and Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the signing of a €24.5 million financing agreement. The venture loan is intended to … open hexagon level packsWitrynaAs of February 2024 Immunic's TTM earnings are -$83.89 M. companies: 7,303 total market cap: $84.738 T. Global ranking; Ranking by countries. America ... The … open hidden files on iphone using shortcutsWitryna6 kwi 2024 · Immunic, Inc. meldet Ergebnis für das am 31. Dezember 2024 beendete Geschäftsjahr. 22.02. Immunic, Inc. ist ein biopharmazeutisches Unternehmen im klinischen Stadium mit einer Pipeline von selektiven oralen Immunologie-Therapien, die sich auf die Behandlung von chronischen Entzündungs- und … iowa state texas game time